Compare Eli Lilly And Co (LLY) vs Vale SA (VALE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Vale SA — how do they compare? Eli Lilly And Co trades at $1,147.06 (market cap $1.02T), while Vale SA trades at $14.13 (market cap $59.07B). The key difference: Eli Lilly And Co is far larger — about 17.3× Vale SA's market cap, and Vale SA pays the higher dividend (8.93%). Which is the better fit depends on your goals.
| LLY | VALE | |
|---|---|---|
Market Cap | $1.02T | $59.07B |
Sector | Health | Basic Materials |
52-Week High | $1.24K | $17.82 |
52-Week Low | $625.65 | $9.53 |
Enterprise Value | $1.06T | $75.99B |
Dividend Yield | 0.6% | 8.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Vale SA
Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →
